PLG and nervous system disorder: In neurologic diseases, fibrinolysis is impaired, by either upregulation of inhibitors of plasmin generation, such as plasminogen activator inhibitor 1 (PAI-1), or by Aβ binding to the plasmin-binding site on fibrin inhibiting its degradation (24, 90).